thiotepa has been researched along with Cells, Neoplasm Circulating in 12 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Furthermore, we evaluated the times for hematopoietic reconstitution in a group of five BC patients in the high-risk adjuvant situation who underwent HD chemotherapy and hematopoietic rescue with positive/negative selected stem cells and compared it with our own data from 10 BC patients who, after identical HD therapy, received only positively selected CD34+ cells and 14 patients who, after identical HD therapy, received autografts purged by incubation with toxic ether lipids (ET-18-OCH3)." | 2.69 | Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. ( Berdel, WE; Cassens, U; Fietz, T; Hilgenfeld, E; Hoffmann, M; Hoppe, B; Kienast, J; Knauf, WU; Koenigsmann, M; Mohr, M; Sibrowski, W; Thiel, E, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Stefanovic, S | 1 |
| Deutsch, TM | 1 |
| Riethdorf, S | 2 |
| Fischer, C | 1 |
| Hartkopf, A | 1 |
| Sinn, P | 1 |
| Feisst, M | 1 |
| Pantel, K | 2 |
| Golatta, M | 1 |
| Brucker, SY | 1 |
| Sütterlin, M | 1 |
| Schneeweiss, A | 1 |
| Wallwiener, M | 1 |
| Vilsmaier, T | 1 |
| Heidegger, HH | 1 |
| Schröder, L | 1 |
| Trapp, E | 1 |
| Zehni, AZ | 1 |
| Rack, B | 1 |
| Janni, W | 1 |
| Mahner, S | 1 |
| Weissenbacher, T | 1 |
| Jeschke, U | 1 |
| Mumm, JN | 1 |
| Yi, B | 1 |
| Wu, T | 1 |
| Zhu, N | 1 |
| Huang, Y | 1 |
| Yang, X | 1 |
| Yuan, L | 1 |
| Wu, Y | 1 |
| Liang, X | 1 |
| Jiang, X | 1 |
| Park, C | 1 |
| Abafogi, AT | 1 |
| Ponnuvelu, DV | 1 |
| Song, I | 1 |
| Ko, K | 1 |
| Park, S | 1 |
| Cheng, JP | 1 |
| Yan, Y | 1 |
| Wang, XY | 1 |
| Lu, YL | 1 |
| Yuan, YH | 1 |
| Jia, J | 1 |
| Ren, J | 1 |
| COLE, WH | 1 |
| ROBERTS, SS | 1 |
| WEBB, RS | 1 |
| STREHL, FW | 1 |
| OATES, GD | 1 |
| MEHTA, RD | 1 |
| RIDDELL, AG | 1 |
| Mohr, M | 1 |
| Hilgenfeld, E | 1 |
| Fietz, T | 1 |
| Hoppe, B | 1 |
| Koenigsmann, M | 1 |
| Hoffmann, M | 1 |
| Knauf, WU | 1 |
| Cassens, U | 1 |
| Sibrowski, W | 1 |
| Kienast, J | 1 |
| Thiel, E | 1 |
| Berdel, WE | 1 |
| Peliukova, RN | 1 |
| Slack, NH | 1 |
| Blumenson, LE | 1 |
| Bross, ID | 1 |
| Fisher, B | 1 |
1 trial available for thiotepa and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combi | 1999 |
11 other studies available for thiotepa and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2020 |
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Ca | 2021 |
The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcino | 2021 |
Enhanced Luminescent Detection of Circulating Tumor Cells by a 3D Printed Immunomagnetic Concentrator.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Count; Cyclophosphamide; Humans; L | 2021 |
Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carboplatin; Chromoso | 2010 |
MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cell | 2011 |
DISSEMINATION OF CANCER WITH SPECIAL EMPHASIS ON VASCULAR SPREAD AND IMPLANTATION.
Topics: Geriatrics; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms; Ne | 1965 |
CANCER CELLS IN BLOOD OF PATIENTS WITH MALIGNANT MELANOMA TREATED BY REGIONAL PERFUSION.
Topics: Blood; Cell Nucleus; Chemotherapy, Cancer, Regional Perfusion; Cytoplasm; Drug Therapy; Humans; Mela | 1965 |
[Effect of thiophosphamide on carcinomia in rats with sarcoma SSK].
Topics: Animals; Female; Neoplastic Cells, Circulating; Rats; Sarcoma, Experimental; Thiotepa | 1976 |
Therapeutic implications from a mathematical model characterizing the course of breast cancer.
Topics: Breast Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; | 1969 |
Prospects for the control of metastases.
Topics: Anticoagulants; Breast Neoplasms; Female; Fluorouracil; Humans; Lymphatic Metastasis; Neoplasm Recur | 1969 |